Chief Marketing Officer

The energy sectors of Ukraine and Poland are entering a transformative era, shaped by shifting energy policies, the European Green Deal, and the pressing need for infrastructure modernization. Both countries, strategically located in Europe, offer complementary strengths that create unparalleled opportunities for collaboration and investment in renewable energy, grid modernization, and sustainable energy solutions.

The European Green Deal continues to accelerate investment into renewable energy, providing a favorable framework for innovation and growth. Poland is undergoing a profound shift in its energy mix, moving away from coal as a primary energy source. This transition, while challenging, positions the country to lead in the development of wind, solar, and other renewable energy technologies. At the same time, Ukraine is emerging as one of Europe’s most promising renewable energy markets. With its high levels of solar insolation, favorable wind speeds, and competitive compensation mechanisms, Ukraine offers a fertile environment for renewable energy projects. Its energy system, synchronized with the European grid, further enhances its attractiveness to investors.

Collaboration between Poland and Ukraine in renewable energy development is particularly timely. Poland’s expertise in deploying offshore wind and advancing grid integration can complement Ukraine’s vast untapped potential in solar and onshore wind energy. By working together, the two countries can create a renewable energy corridor that supports Europe’s broader climate and energy goals.

The rapid expansion of renewable energy across Europe has highlighted a critical challenge: the need for reliable grid balancing and energy storage solutions. In Poland, the shift away from coal-fired power plants has increased demand for flexible, maneuverable energy systems such as gas turbines, battery storage, and small hydropower plants. In Ukraine, this need is even more acute, driven by the destruction of thermal power generation infrastructure during the conflict. Investors in energy storage and peak-balancing solutions stand to benefit from attractive feed-in tariffs and incentives, making this a key area of opportunity.

As both countries navigate these energy transitions, nuclear power is re-emerging as a cornerstone of energy security. The EU’s evolving energy policy increasingly embraces nuclear generation after decades of resistance, with Eastern Europe positioned as a hub for small and medium nuclear reactor (SMR) deployment. Ukraine, historically the second-largest nuclear energy producer in Europe, is uniquely well-positioned to capitalize on this trend. With deep expertise, an advanced grid infrastructure, and a commitment to SMR development, Ukraine could play a pivotal role in Europe’s nuclear energy revival. Poland, meanwhile, has recently committed to building its own nuclear power capacity, and the shared expertise and regional collaboration between the two nations could drive faster and more efficient deployment of these projects.

Rebuilding Ukraine’s energy infrastructure in the aftermath of the war is an essential component of the country’s economic recovery. Modernizing its energy grid, integrating advanced technologies, and rebuilding renewable and nuclear capacity represent not only a necessity but also an opportunity to create a cleaner, more resilient energy system. Poland, as Ukraine’s critical logistics and investment hub, is ideally positioned to provide support in this process. The synergy between the two nations in energy infrastructure development could set the foundation for a more interconnected and sustainable regional energy network.

Both countries’ strategic locations amplify their importance in Europe’s evolving energy landscape. Situated on the main transit routes between Asia and Europe, as well as along the critical north-south and east-west corridors, Poland and Ukraine are poised to become central players in the energy supply chain. Projects such as the Baltic Pipe, Via Carpathia, and expanded cross-border interconnectors reinforce the potential for integrating energy markets, creating shared resilience, and driving mutual prosperity.

The opportunities in energy cooperation between Poland and Ukraine are unparalleled. From renewable energy development and grid modernization to nuclear revival and innovative energy storage solutions, the two nations are poised to lead the region in the transition to a sustainable energy future. Their collaboration will not only drive regional energy security but also position them as essential contributors to Europe’s clean energy ambitions, creating lasting economic and environmental benefits for both nations and the broader continent.

Our investment approach in the energy sector is centered on identifying and supporting transformative projects that address both the immediate and long-term energy needs of Poland and Ukraine. Each country presents unique opportunities that align with our investment philosophy, combining the pressing need for infrastructure modernization with the potential for significant growth in renewable energy and energy storage solutions.

In Ukraine, the post-conflict landscape offers a rare and dynamic opportunity to rebuild the country’s energy infrastructure. With much of the energy generation capacity—especially in thermal power plants—having been significantly impacted by the war, Ukraine is now entering a phase of rebuilding that will require substantial investments in renewable energy, grid modernization, and energy storage. The development of "energy islands" and decentralized power generation systems probably will be a focus. These systems, which reduce dependency on central grids and offer greater resilience against geopolitical risks, represent a forward-looking approach to energy security. Our investment strategy in Ukraine will focus on leveraging this opportunity, backing renewable energy projects such as solar, wind, and bioenergy in synergy with agricultural production, alongside energy storage and grid balancing solutions that are crucial for the country's energy transition.

Poland, meanwhile, is at a critical juncture in its own energy transition. The shift away from coal has accelerated the development of renewable energy, with wind, solar, and energy storage technologies gaining momentum. In addition to traditional renewables, we are also keenly interested in projects that address "soft" energy solutions, such as energy management and balancing technologies. These projects play a pivotal role in ensuring that intermittent renewable energy sources, like wind and solar, can be integrated seamlessly into the grid. We view energy storage, battery technologies, and smart grid solutions as central to Poland's ability to manage its energy transition efficiently, enabling the country to maintain stability while reducing its reliance on fossil fuels. Poland’s leadership in offshore wind and grid infrastructure, combined with the growing need for energy optimization, presents an exciting opportunity for innovative and scalable solutions.

In both countries, we also see significant potential in bioenergy projects that can leverage agricultural by-products. Ukraine’s vast agricultural sector, alongside Poland’s established expertise in bioenergy, provides a unique synergy to capitalize on sustainable energy production. Bioenergy solutions tied to agriculture not only offer cleaner energy alternatives but also create a circular economy that benefits both the energy and agricultural sectors.

In both regions, our approach will involve investing in projects that offer strategic scalability and resilience, with a focus on mid- to large-scale projects that align with our broader portfolio strategy. The energy storage market, grid modernization, and energy management systems will be key areas of focus in Poland, while renewable energy infrastructure rebuild and energy security in Ukraine will be at the forefront of our investment priorities.

Moreover, the emerging collaboration between Poland and Ukraine in energy, such as joint grid modernization efforts, cross-border energy trade, and shared energy storage projects, presents a powerful avenue for regional cooperation. Both countries are strategically located along critical energy transit routes in Europe, making them key players in the broader European energy supply chain. This interconnectedness provides a unique opportunity to create a more resilient, sustainable energy network, with the potential for shared energy resources and joint projects that contribute to the broader European Green Deal and the energy transition across the continent.

The Healthcare & Biotech Asset Class is spearheaded by Eduard Zhalovaga, who brings over 15 years of leadership experience in the pharmaceutical industry, with a track record that includes positions at Bayer, Pfizer, Merck, and other global leaders.

Our healthcare investments are centered on cutting-edge technologies and revolutionary therapies designed to transform patient care. We focus on businesses leading breakthrough innovations, such as life-saving treatments, precision medicine, and advanced biotechnologies that are set to redefine healthcare.

Capitalizing on Healthcare Innovation in a Disruptive Era

Navigating Unprecedented Opportunities
The healthcare and biotech industries are experiencing transformative shifts, catalyzed by global health crises and geopolitical tensions. As traditional healthcare models face pressure from aging demographics and disrupted supply chains, innovation is thriving. This creates a compelling opportunity for investors to participate in a sector poised for long-term growth.

A Fusion of Innovation and Market Demand
There is a growing gap between the demand for advanced healthcare solutions and the capacity of existing systems to meet it. The pandemic accelerated the adoption of new technologies, from personalized medicine to digital health, yet healthcare infrastructure remains underdeveloped in many areas. This presents a prime moment for investment in early-stage biotech and healthcare technology firms that are rapidly developing cutting-edge solutions.

Strategic Entry Ahead of Institutional Momentum
As large institutional players and major pharmaceutical companies remain cautious in the post-pandemic landscape, there is a window of opportunity for smaller, agile funds to secure strategic positions. These early investments enable capturing value before larger players flood the market, driving up valuations.

Precision Medicine and Breakthrough Therapeutics
The rise of precision medicine, particularly in the areas of gene therapy, mRNA technology, and targeted cancer treatments, is unlocking new possibilities for patient-specific care. While these innovations require substantial upfront capital, the potential for exponential returns as they approach commercialization makes them highly attractive investment targets.

Healthcare Technology: Digital Health and Telemedicine
Telemedicine and digital health tools have become integral to healthcare delivery, with the sector now focused on expanding AI-driven diagnostics, digital therapeutic platforms, and remote patient monitoring systems. This shift opens high-margin, scalable investment opportunities, as more healthcare providers and consumers turn to digital solutions for efficient, cost-effective care.

Early Detection and Diagnostics Platforms
As global health challenges persist, from pandemics to chronic diseases, the demand for accurate and early diagnostics is surging. Firms advancing next-generation sequencing (NGS) and at-home testing technologies represent a rapidly growing sector. These innovations not only improve patient outcomes but also reduce long-term healthcare costs, offering strong potential for sustained returns.

Mid-Stage Biotech R&D
Biotech firms in mid-stage development often struggle to secure funding for promising research due to economic uncertainty. Investing in these firms, particularly those with projects that have already gained regulatory approval, offers a lower-risk entry into breakthrough innovations. This strategy accelerates the commercialization process while allowing investors to acquire undervalued assets poised for growth.

Addressing Global Healthcare Needs
With an aging population and rising incidences of chronic diseases such as diabetes, neurodegenerative conditions, and heart disease, healthcare systems are under pressure. Companies focused on novel treatments and care models that address these long-term trends are positioned to deliver strong, sustainable returns as they provide essential solutions to a growing market.

Unlocking Unique Investment Opportunities in Healthcare and Biotech

Our diverse pipeline offers exclusive access to a range of high-potential healthcare and biotech ventures, exemplifying the breadth of opportunities we've identified. These projects, carefully selected for their groundbreaking potential, provide unparalleled possibilities for investors seeking transformative growth in sectors that are reshaping the future of medicine.

One notable example is a biotechnology firm that specializes in prescription digital therapeutics, leveraging AI-powered mobile applications to complement traditional treatments. This firm, with regulatory approvals and strategic partnerships already in place, exemplifies how digital health solutions are rapidly becoming integral to healthcare delivery.

Another venture focuses on advancing targeted drug delivery systems through Small Molecule Drug Conjugates (SMDCs), offering transformative potential in oncology. By ensuring more effective tumor targeting, this technology stands to significantly improve patient outcomes, addressing unmet needs in cancer treatment.

We also have access to an innovative robotics company developing a precision MRI-guided platform for neurosurgical procedures. With live imaging and unmatched accuracy, this technology is poised to revolutionize surgical approaches, offering a prime opportunity for investment in cutting-edge medical devices.

In the realm of oxygen therapeutics, another project in our portfolio has pioneered Hemoglobin-Based Oxygen Carriers (HBOCs) that improve oxygen delivery to tissues, with applications in both human and veterinary medicine. The company’s ongoing success, including regulatory approvals and cutting-edge organ perfusion technology, highlights its leadership in this critical area.

These are just a few examples from our wide-ranging pipeline of projects, each offering unique and unmatched potential for high returns. Our strategic access to such innovative ventures ensures that investors gain entry into groundbreaking developments at the forefront of healthcare and biotechnology, providing investment opportunities not readily available elsewhere.